0001367644-20-000134.txt : 20200812 0001367644-20-000134.hdr.sgml : 20200812 20200812165250 ACCESSION NUMBER: 0001367644-20-000134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200811 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOULWAN GEORGE A CENTRAL INDEX KEY: 0001222197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 201096009 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_159726555510283.xml FORM 4 X0306 4 2020-08-11 0 0001367644 Emergent BioSolutions Inc. EBS 0001222197 JOULWAN GEORGE A 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2020-08-11 4 S 0 6000 124.1059 D 26771 D Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $121.78 to $125.14. /s/ S. Scott Lieberman, Attorney-in-fact 2020-08-12